Header Logo

Connection

RAJYALAKSHMI LUTHRA to Drug Therapy, Combination

Back to Details
This is a "connection" page, showing publications RAJYALAKSHMI LUTHRA has written about Drug Therapy, Combination.
RAJYALAKSHMI LUTHRA
Connection Strength
0.128
Drug Therapy, Combination
  1. A phase II trial of ruxolitinib in combination with azacytidine in myelodysplastic syndrome/myeloproliferative neoplasms. Am J Hematol. 2018 02; 93(2):277-285.
    View in: PubMed
    Score: 0.100
  2. Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue. An uncontrolled trial. Ann Intern Med. 1999 Jul 20; 131(2):88-95.
    View in: PubMed
    Score: 0.028
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.